Ontario plans to expand newborn screening:
This article was originally published in Clinica
Ontario's newborn screening programme, launched at the end of last month, will provide Can$7m (US$6m) annually to expand the number of tests available, including for several rare genetic disorders. The funds will be used to support the laboratory and to buy high-tech screening equipment. The overall Can$18m programme, announced at the end of last year (see Clinica No 1184, p 12), is unique in Canada for testing for blood disorders in newborns, such as sickle cell disease. It is expected to serve around 130,000 families each year.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.